New agreement to boost vaccine production under Quad partnership for Indo-Pacific in the offing

Current (GK) International Affairs

An agreement on a new vaccine manufacturing facility in Hyderabad to support the Quad’s plan of delivering one billion doses of Covid-19 shots will be signed during an upcoming visit to India by the US development bank’s chief.
US International Development Finance Corporation (DFC) chief operating officer David Marchick will travel to South Africa and India during October 18-26 to take forward investments to boost global health and expand Covid-19 vaccine production across the developing world.
Marchick and his delegation will travel to Hyderabad after arriving in India on October 24 to visit Biological E, which has been selected to produce one billion doses of vaccines to be rolled out by the end of 2022 under the vaccine partnership launched by the Quadrilateral Security Dialogue or Quad.
The US delegation will “participate in a signing ceremony to open a new facility with substantial capacity for vaccine manufacturing”, according to a statement from the DFC.
“This work is in support of the historic commitment set out by President [Joe] Biden and his counterparts in the Quad – Australia, India, Japan, and the United States,”